Peculiarities of management of elderly patients with chronic cerebral ischemia
Mkhitaryan Elen Araikovna - PhD, Associate Professor of the Department of Aging Diseases of the Faculty of Continuing Professional Education of the Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, Head of the Laboratory of Neurogeriatrics of the Russian Scientific Clinical Center
Evgeniya Viktorovna Yekusheva , Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation at the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia
Announcement:
One of the most common causes of cognitive impairment in elderly and senile patients is chronic cerebral ischemia (CCI). Given that many elderly patients believe that memory impairment and other cognitive functions are a manifestation of the normal aging process, such patients rarely complain of cognitive decline when visiting a doctor. The line between progressive moderate cognitive impairment and the initial stages of dementia is very thin. Therefore, it is extremely important to identify the moment of this transition in time and manage to adequately help the patient in time.
In everyday practice, various screening tests and scales are used to detect cognitive impairment; however, the primary screening scale for vascular cognitive impairment is the Montreal Cognitive Assessment Scale. According to clinical guidelines, diagnosis should be performed during the general therapeutic phase. After examination and diagnosis, the patient moves on to the next stage—treatment.
Pharmacotherapy of elderly patients is a complex task. First of all, it is extremely important to avoid polypharmacy when choosing a drug.
Mexidol®allows is a multimodal neurocytoprotector; the combination of effects of Mexidol®for the treatment of the main clinical symptoms of cerebrovascular pathology, avoiding the need for additional medications due to the multimodality of its effects, improving patient adherence to treatment and increasing the safety of pharmacotherapy.